97 related articles for article (PubMed ID: 7700929)
1. Concentration of large volume peripheral blood stem cell products using the COBE 2991.
Eby LL; Schepers KG; Shulman-Roskes EM; Noga SJ; Davis JM
Prog Clin Biol Res; 1994; 389():631-7. PubMed ID: 7700929
[No Abstract] [Full Text] [Related]
2. Large volume leukapheresis following peripheral blood stem cell mobilization by cyclophosphamide and granulocyte-macrophage colony stimulating factor.
Safran H; Caguioa P; Tansan S
Prog Clin Biol Res; 1994; 389():639-42. PubMed ID: 7700930
[No Abstract] [Full Text] [Related]
3. Component processing and intraoperative autotransfusion during bone marrow harvest.
Cook-Craig A; Owen A; Reeder G; Drobyski W; Horowitz M; Brunner J; Flomenberg N; Keever C
Prog Clin Biol Res; 1994; 389():613-9. PubMed ID: 7700927
[No Abstract] [Full Text] [Related]
4. Tumor contamination in stem cell products from patients with neuroblastoma and breast cancer.
Moss TJ
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S17. PubMed ID: 8899162
[No Abstract] [Full Text] [Related]
5. Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol.
Hollingsworth KL; Williams SF; Blake MS; Pothiawala M; Mick R; Larson RA; Bender JG
Prog Clin Biol Res; 1994; 389():695-704. PubMed ID: 7700937
[No Abstract] [Full Text] [Related]
6. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.
Kwekkeboom J; Buurman DE; Ploemacher RE; Baars JW; Loos HA; Slaper-Cortenbach IC
Exp Hematol; 1998 May; 26(5):400-8. PubMed ID: 9590656
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
[TBL] [Abstract][Full Text] [Related]
9. Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.
Warkentin PI; Jackson JD; Letheby B; Kessinger A
Prog Clin Biol Res; 1994; 389():643-7. PubMed ID: 7700931
[No Abstract] [Full Text] [Related]
10. Stem cells for grafting.
Charbord P
Transfus Sci; 1992; 13(4):375-85. PubMed ID: 10150138
[No Abstract] [Full Text] [Related]
11. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
12. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
[TBL] [Abstract][Full Text] [Related]
13. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
Schots R; Van Riet I; Damiaens S; Flament J; Lacor P; Staelens Y; Steenssens L; van Camp B; De Waele M
Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
[TBL] [Abstract][Full Text] [Related]
14. High efficiency of CD34+ selection by removal of platelets from the apheresis product.
Schreiner T; Maccari B; Erne E; Bischof C; Wiesneth M
Beitr Infusionsther Transfusionsmed; 1997; 34():144-9. PubMed ID: 9356665
[No Abstract] [Full Text] [Related]
15. [Effect of processed blood volume, leukocyte count and concentration of CD34-positive cells in peripheral blood on efficiency of stem cell apheresis].
Matic GB; Ullrich H; Barlage S; Rothe G; Schmitz G
Beitr Infusionsther Transfusionsmed; 1997; 34():139-43. PubMed ID: 9417337
[TBL] [Abstract][Full Text] [Related]
16. Positive selection of CD34+ cells by immune affinity.
Höcker P; Kührer I; Worel N; Leitner G; Kalhs P; Greinix H; Gerhartl K
Beitr Infusionsther Transfusionsmed; 1997; 34():166-70. PubMed ID: 9356669
[No Abstract] [Full Text] [Related]
17. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
[TBL] [Abstract][Full Text] [Related]
18. The influence of extracorporeal peripheral blood stem cell apheresis on platelet antigens.
Gutensohn K; Hummel K; Goepfert C; Riggert J; Cassens U; Kuehnl P
Beitr Infusionsther Transfusionsmed; 1997; 34():153-6. PubMed ID: 9356667
[No Abstract] [Full Text] [Related]
19. Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.
Glück S; Ross AA; Layton TJ; Ostrander AB; Goldstein LC; Porter K; Ho AD
Biol Blood Marrow Transplant; 1997 Dec; 3(6):316-23. PubMed ID: 9502299
[TBL] [Abstract][Full Text] [Related]
20. Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer.
de Arriba F; Corral J; Ayala F; Heras I; Moraleda JM; Osma MM; González-Conejero R; Ortuño F; Vicente V
Bone Marrow Transplant; 1999 Mar; 23(6):621-4. PubMed ID: 10217194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
